Skip to content
HowShorted

CorMedix Inc. short interest in 2020

In 2020, CorMedix Inc.'s disclosed short interest ran from 15.85% of shares outstanding on 15 Jan 2020 to 9.49% on 31 Dec 2020, a change of -6.36 percentage points. The year's high was 15.92% on 15 Jul 2020 and its low 9.35% on 13 Nov 2020, averaging 12.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.42 days on 14 Feb 2020. Full history: CorMedix Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CorMedix Inc. in 2020

2020 in figures

Start of year
15.85% (15 Jan 2020)
End of year
9.49% (31 Dec 2020)
Change
-6.36 pp
High
15.92% (15 Jul 2020)
Low
9.35% (13 Nov 2020)
Average
12.49%
Highest days to cover
22.42 (14 Feb 2020)
SEC filings marked
8

Every report in 2020

CorMedix Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202015.85%19.41
31 Jan 202015.76%21.82
14 Feb 202015.04%22.42
28 Feb 202014.63%13.20
13 Mar 202013.77%10.91
31 Mar 202013.77%10.0010-K filed, results (8-K)
15 Apr 202013.85%20.42
30 Apr 202013.89%21.24
15 May 202013.81%17.8010-Q filed, results (8-K)
29 May 202011.50%18.89
15 Jun 202012.24%14.01
30 Jun 202012.50%15.04
15 Jul 202015.92%10.09
31 Jul 202012.10%7.04
14 Aug 202011.65%8.2010-Q filed, results (8-K)
31 Aug 202012.00%8.99
15 Sep 202011.43%9.29
30 Sep 202011.44%4.11
15 Oct 20209.96%11.03
30 Oct 20209.95%19.27
13 Nov 20209.35%18.3710-Q filed, results (8-K)
30 Nov 202010.20%6.82
15 Dec 20209.61%11.07
31 Dec 20209.49%6.08

See also: CorMedix Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.